«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

20卷

期数:

2014年04期

页码:

260-263

栏目:

基础医学

出版日期:

2014-07-08

文章信息/Info

Title:

Effects of ceramide on hepatic fibrosis

文章编号:

1006-8147（2014）04-0260-04

作者:

徐亚洁; 张晓燕; 马淑晶; 杜 岩; 方步武

（天津医科大学药理学教研室，天津 300070）

Author(s):

XU Ya-jie;  ZHANG Xiao-yan;  MA Shu-jing;  DU Yan;  FANG Bu-wu

(Department of Pharmacology, Tianjin Medical University, Tianjin 300070, China)

关键词:

神经酰胺; 肝纤维化; 油酰乙醇胺; 丙咪嗪

Keywords:

ceramide;  hepatic fibrosis;  N-oleoylethanolamine;  imipramine

分类号:

R96

DOI:

-

文献标志码:

A

摘要:

目的：探讨神经酰胺代谢酶抑制剂油酰乙醇胺（NOE）和丙咪嗪（Imi）对人源肝星状细胞（HSCs）LX-2中神经酰胺含量的影响，并探讨神经酰胺在肝纤维化治疗中的作用。方法：实验分为给药组（NOE组终浓度为50、75、100 μmol/L；Imi组终浓度为10、20、30 μmol/L），乙醇对照组（乙醇终浓度为1%），DMSO组（DMSO终浓度为1‰）。高效液相法测定HSCs内神经酰胺的含量，四甲基偶氮唑盐（MTT）法检测HSCs的增殖情况，比色法检测乳酸脱氢酶（LDH）的活性，酶消化法测定羟脯氨酸（Hyp）的含量。结果：与乙醇组比较，NOE各浓度组可显著提高HSCs内神经酰胺的含量（P<0.05）；对HSCs的抑制作用呈剂量-效应关系；各浓度组LDH活性与乙醇组比较，无显著性差异（P>0.05）；且各浓度组均可显著降低HSCs上清液中羟脯氨酸的含量（P<0.05）。30 μmol/L Imi作用24 h后，与DMSO组比较，可降低HSCs内神经酰胺的含量，促进HSCs的增殖，并可升高HSCs上清液中羟脯氨酸的含量，且差异均具有统计学意义（P<0.05）。结论：神经酰胺代谢酶抑制剂对HSCs内神经酰胺的含量有显著影响，且神经酰胺可通过抑制HSCs细胞的增殖、减少胶原蛋白的合成来发挥抗肝纤维化作用。

Abstract:

Objective：To investigate the effects of ceramide metabolism inhibitors, N-oleoylethanolamine(NOE)and Imipramine(Imi) on intracellular contents in HSCs LX-2, and to explore the effect of ceramide on hepatic fibrosis. Methods：The experimental groups included three NOE-treated groups with 50, 75, 100 μmol/L NOE, three Imi-treated groups with 10, 20, 30 μmol/L Imi, one alcohol-treated group with 1% alcohol and one DMSO-treated group with 1‰ DMSO. The content of ceramide was determined by HPLC method, MTT assay was applied to detect the rate of cellular proliferation. The activity of LDH was determined by colorimetric method and the content of hydroxyproline (Hyp) was obtained using enzyme digestion method. Results: Compared with alcohol-treated group, NOE significantly increased the content of ceramide in HSCs(P<0.05). MTT Analysis revealed that HSCs treated with various concentrations of NOE(50~100 μmol/L) were inhibited on dose –effect relationships. activity of LDH（改为LDH activity） in NOE-treated groups had no significant difference compared with alcohol-treated group(P>0.05) while content of Hyp in NOE-treated groups was significantly decreaced compared with alcohol-treated group(P<0.05); Compared with DMSO-treated group, 30 μmol/L Imi could decreace the concentration of ceramide in HSCs, promote the proliferation of HSCs and increase the content of hydroxyproline in HSCs. All of these differences were significant (P<0.05). Conclusion: The ceramide metabolism inhibitors could change the concentration of ceramide effectively, and the anti-fibrogenic mechanisms of ceramide might inhibit the activation of HSCs, and decrease the synthesis of collagen.

参考文献/References:

[1]Majumder S, Dey R, Bhattacharjee S, et al. Leishmania-induced biphasic ceramide Generation in macrophages is crucial for uptake and survival of the parasite[J]. J Infect Dis, 2012,205(10):1607
[2]Zhu W, Wang X, Zhou Y, et al. C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells[J]. Int J Mol Sci, 2014,15(2):3336 [3]Mencarelli C, Martinez-Martinez P. Ceramide function in the brain: when a slight tilt is enough[J]. Cell Mol Life Sci, 2013,70(2):181
[4]Mohammadtaghvaei N, Taheripak G, Taghikhani M, et al. Palmitate-induced PTP1B expression is mediated by ceramide-JNK and nuclear factor κB (NF-κB) activation[J]. Cell Signal, 2012,24(10):1964
[5]Glaros E N, Kim W S, Garner B. Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition[J]. Clin Sci (Lond), 2010,118(12):727
[6]Liangpunsakul S, Rahmini Y, Ross R A, et al. Imipramine blocks ethanol-induced ASMase activation, ceramide Generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice[J]. Am J Physiol Gastrointest Liver Physiol, 2012,302(5):G515
[7]娄婷婷，李英娴，方步武，等. 测定生物样本中神经酰胺含量的HPLC-FLD法[J]. 药物分析杂志, 2012,32(10):1807
[8]Shea B S, Tager A M. Sphingolipid regulation of tissue fibrosis[J]. Open Rheumatol J, 2012,6(Suppl 1:M8):123
[9]Artetxe I, Sergelius C, Kurita M, et al. Effects of sphingomyelin headgroup size on interactions with ceramide[J]. Biophys J, 2013,104(3):604
[10]Woodhoo A, Iruarrizaga-Lejarreta M, Beraza N, et al. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis[J]. Hepatology, 2012,56(5):1870
[11]Lakner A M, Steuerwald N M, Walling T L, et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis[J]. Hepatology, 2012,56(1):300
[12]Longxi P, Buwu F, Yuan W, et al. Expression of p53 in the effects of artesunate on induction of apoptosis and inhibition of proliferation in rat primary hepatic stellate cells[J]. PLoS One, 2011,6(10):e26500
[13]Qian H, Shi J, Fan T T, et al. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats[J]. World J Gastroenterol, 2014,20(7):1822
[14]Liedtke C, Luedde T, Sauerbruch T, et al. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects[J]. Fibrogenesis Tissue Repair, 2013,6(1):19
[15]Liu L, Yannam G R, Nishikawa T, et al. The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis[J]. Hepatology, 2012,55(5):1529

相似文献/References:

[1]刘文东,李英娴,娄婷婷,等.青蒿琥酯对肝纤维化大鼠肝组织基质金属蛋白酶表达的影响[J].天津医科大学学报,2013,19(05):362.
[2]马淑晶,张晓燕,徐亚洁,等.青蒿琥酯通过上调神经酰胺抑制肝星状细胞增殖并诱导其凋亡[J].天津医科大学学报,2014,20(04):253.
　MA Shu-jing,ZHANG Xiao-yan,XU Ya-jie,et al.Artesunate inhibits the proliferation of hepatic stellate cells and induces apoptosis by upregulating ceramide[J].Journal of Tianjin Medical University,2014,20(04):253.
[3]张晓燕,马淑晶,徐亚洁,等.青蒿琥酯对人源肝星状细胞LX-2增殖、胶原产生以及KLF6表达的影响[J].天津医科大学学报,2014,20(04):257.
　ZHANG Xiao-yan,MA Shu-jing,XU Ya-jie,et al.Effects of artesunate on cell proliferation，collagen generated and KLF6 expression in hepatic stellate cells[J].Journal of Tianjin Medical University,2014,20(04):257.
[4]李萌乾,王青松,郭正隆,等.诱导型狨猴肝纤维化模型的建立 [J].天津医科大学学报,2014,20(06):433.
　LI Meng-qian,WANG Qing-song,GUO Zheng-long,et al. Establishment of drug-induced common marmoset model for hepatic fibrosis[J].Journal of Tianjin Medical University,2014,20(04):433.
[5]李立楠,李杉杉,刘 悦,等.神经酰胺诱导LX-2细胞凋亡抑制肝纤维发生的作用[J].天津医科大学学报,2016,22(04):283.
　LI Li-nan,LI Shan-shan,LIU Yue,et al.Effects of ceramide on promoted LX-2 cell apoptosis and inhibitting hepatic fibrosis[J].Journal of Tianjin Medical University,2016,22(04):283.
[6]刘 悦,李杉杉,唐诗慧,等.蒿鳖养阴软坚方通过激活Nrf2/NQO1信号通路抑制肝纤维化发生[J].天津医科大学学报,2018,24(01):19.
　LIU Yue,LI Shan-shan,TANG Shi-hui,et al.Effects of HaobieYangyinRuanjian on inhibition of hepatic fibroesis through upregulated Nrf2/NQO1 pathway[J].Journal of Tianjin Medical University,2018,24(04):19.
[7]卢娜,方步武.蒿鳖养阴软坚方对刀豆球蛋白A诱导的肝纤维化Nrf2/HO-1信号通路影响[J].天津医科大学学报,2018,24(02):112.
　LU Na,FANG Bu-wu.Effect of Haobie yangyin ruanjian prescription on Nrf2/HO-1 signaling pathway in ConA-induced hepatic fibrosis[J].Journal of Tianjin Medical University,2018,24(04):112.
[8]张丽,方步武.虎杖苷抑制肝星状细胞增殖活化的作用和机制研究[J].天津医科大学学报,2020,26(04):309.
　ZHANG Li,FANG Bu-wu.Inhibitory effects and mechanism of Polydatin on the proliferation and activation of hepatic stellate cell[J].Journal of Tianjin Medical University,2020,26(04):309.
[9]靳悦,汪河,李明威,等.CD24 通过调节肝内Ly6Clo 巨噬细胞亚群中PDGF-B 的 分泌抑制肝纤维化进程[J].天津医科大学学报,2022,28(03):260.
　JIN Yue,WANG He,LI Ming-wei,et al.CD24 inhibits the liver fibrosis process by regulating the secretion of PDGF -B in hepatic Ly6Clo macrophage subset[J].Journal of Tianjin Medical University,2022,28(04):260.
[10]刘志杰综述,詹江华审校.肝巨噬细胞在胆道闭锁肝纤维化中的作用[J].天津医科大学学报,2023,29(04):453.

备注/Memo

备注/Memo:

基金项目 国家自然科学基金资助项目（30772856）
作者简介 徐亚洁（1988-），女，硕士在读，研究方向：中药药理；通信作者：方步武，E-mail：fangdch@yahoo.com.cn。

常用功能

更新日期/Last Update: 2014-06-06